Document is current
Any future updates will be listed below
-
Authors
Kalyvianaki, Konstantina https://orcid.org/0000-0002-2145-9430
Malamos, Panagiotis https://orcid.org/0000-0002-5771-5352
Mastrodimou, Niki https://orcid.org/0000-0002-2619-9682
Manoura-Zonou, Ioanna https://orcid.org/0000-0002-0246-0321
Vamvoukaki, Rodanthi https://orcid.org/0000-0002-7798-6264
Notas, George
Malliaraki, Niki https://orcid.org/0000-0001-9372-8639
Moustou, Eleni
Tzardi, Maria
Pirintsos, Stergios https://orcid.org/0000-0002-6287-0795
Lionis, Christos
Sourvinos, George
Castanas, Elias https://orcid.org/0000-0002-8370-1835
Kampa, Marilena https://orcid.org/0000-0002-6324-9570
-
Funding
Funding for this research was provided by:
OLVOS Pharmaceuticals/KA10000
- License Information
-
More Information
Article History
Received: 18 February 2020
Accepted: 12 October 2020
First Online: 9 November 2020
Competing interests
: SP, CL and EC are inventors of a patent (WO2010GB01836 20100929 and additional national related patents) on the use of the three aromatic plants against upper respiratory tract infections. The other authors have nothing to declare.
